Concepedia

L. Tahraoui

LT

6

Publications

193

Citations

6

H-Index

1984

Active since

Affiliations

Smiths Detection (France)(Current)

L. Tahraoui is an author at Smiths Detection (France) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1984–1991

6

Publications

6

Substituted tetrahydro-β-carbolines are possible candidates as endogenous ligand of the [3H]Imipramine recognition site

Salomón Z. Langer, Rita Raisman, L. Tahraoui et al. · European Journal of Pharmacology · 1984 · 64 citations

, , +8

Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3h]paroxetine binding to cerebral cortical membranes of the rat

David Y. Graham, L. Tahraoui, Salomón Z. Langer · Neuropharmacology · 1987 · 62 citations

, , +13

High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.

L. Tahraoui, A. Floch, S. Mondot et al. · Molecular Pharmacology · 1988 · 30 citations

Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.

L. Tahraoui, A. Floch, Icilio Cavero · Journal of Pharmacology and Experimental Therapeutics · 1990 · 14 citations · Full text

The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.

A. Floch, L. Tahraoui, P. Sédivy et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 12 citations

Rows per page

1–5 of 6